Discovery & Innovation

In the first two installments of this series, we explored 2 major reasons why pharmaceutical development and manufacturing (PharmDev) is being...

In the first installment of this series, we explored the Resilience Pivot — why pharmaceutical development and manufacturing (PharmDev) is moving...

As we kick off 2026, the era of predictable, cost-optimized manufacturing has largely been replaced by one of geopolitical shifts...

In a recent article that appeared in the San Diego Union Tribune, Matt McLoughlin, Senior VP Compliance and Category Management at Scientist.com...

This blog post was written by Applied Pathology Systems (APS). Based in Massachusetts, Applied Pathology Systems (APS) is a premier...

Accelerating Discovery. Expanding Possibility As the year draws to a close, we’re proud to reflect on an extraordinary 2025, one that marked a...

This blog post was written by Slingshot Biosciences, a biotechnology company based in Emeryville, CA that develops precision-engineered cell...

While global biopharma conferences offer broad perspectives, true advancement in Chemistry, Manufacturing, and Controls (CMC) and pharmaceutical...

It’s that time of year again — the crucial moment to strategically map out your 2026 conference calendar. The pace of innovation in biopharma never...

This blog post was written by Biointron, a leading high-throughput recombinant antibody/protein expression and discovery service provider. Their...